Chronic immune responses and inflammatory reactions in
rheumatoid arthritis (RA) often cause severe destruction of cartilage and bone, but its mechanism is still a matter of controversy. We reported that
interleukin-6 (IL-6) alone does not induce osteoclast formation, but soluble
interleukin-6 receptors (sIL-6R) triggered the formation in the presence of
IL-6 in cocultures of murine osteoblastic cells and bone marrow cells. In this study, we examined the involvement of sIL-6R and
IL-6 in joint destruction in patients with RA. Although the frequency of patients having osteoclast-like multinucleated cells in synovium derived from the knee joint was not significantly different between RA (65%) and
osteoarthritis (OA) patients (43%), the number of osteoclast-like cells found in the synovium was greater in the former than in the latter. Multinucleated cells obtained from RA synovium expressed the osteoclast-specific phenotype such as
tartrate-resistant acid phosphatase,
carbonic anhydrase II, vacuolar
proton-
ATPase and
vitronectin receptors at similar levels to those from a human
giant cell tumor of bone. The concentration of both
IL-6 and sIL-6R was significantly higher in the synovial fluids from patients with RA than with OA. The concentration of
IL-6 and sIL-6R correlated well with the roentgenologic grades of joint destruction. Dose-response curves for human
IL-6 and human sIL-6R in inducing osteoclast-like cell formation in cocultures indicated that the RA synovial fluids contained sufficient
IL-6 and sIL-6R to induce osteoclastogenesis. When synovial fluids from RA and OA patients were added to the cocultures, some of the RA synovial fluids containing high levels of
IL-6 and sIL-6R stimulated osteoclast-like cell formation, which was strikingly inhibited by adding anti-IL-6R antibody simultaneously. These results suggest that
IL-6 in the RA synovial fluids is at least in part responsible for joint destruction in the presence of sIL-6R through osteoclastogenesis.